Baseline immune architecture provides more informative biomarker potential than single immune-cell markers in bladder cancer
Immune Cell Patterns May Help Predict Bladder Cancer Outcomes
This narrative review examines the tumor immune microenvironment (TIME) in bladder cancer, focusing on how immune cell distribution and func…
Understanding how immune cells behave within a tumor may help doctors better predict how bladder cancer patients will respond to various tre…
Immune-mediated approaches like BCG and oncolytic viruses show the most advanced clinical translation in bladder cancer
Living cancer therapies show promise for bladder cancer
This narrative review examines Living Cancer Therapeutics (LCTs), including bacteria, viruses, and microbiome-based oncobiotics for urinary …
A review finds five ways living therapies like bacteria and viruses could fight bladder cancer, but most are still early-stage.